Lysosomal cysteine cathepsins contribute to proteolytic events promoting tumor growth and metastasis. Their enzymatic activity, however, is tightly regulated by endogenous inhibitors. To investigate the role of cathepsin inhibitor stefin B (Stfb) in mammary cancer, Stfb null mice were crossed with transgenic polyoma virus middle T oncogene (PyMT) breast cancer mice. We show that ablation of Stfb resulted in reduced size of mammary tumors but did not affect their rate of metastasis. Importantly, decrease in tumor growth was correlated with an increased incidence of dead cell islands detected in tumors of Stfb-deficient mice. Ex vivo analysis of primary PyMT tumor cells revealed no significant effects of ablation of Stfb expression on proliferation, angiogenesis, migration and spontaneous cell death as compared with control cells. However, upon treatment with the lysosomotropic agent Leu-Leu-OMe, cancer cells lacking Stfb exhibited a significantly higher sensitivity to apoptosis. Moreover, Stfb-ablated tumor cells were significantly more prone to cell death under increased oxidative stress. These results indicate an in vivo role for Stfb in protecting cancer cells by promoting their resistance to oxidative stress and to apoptosis induced through the lysosomal pathway.
INTRODUCTION
Proteolysis has a crucial role in tumor invasion and metastasis. The roles of lysosomal cysteine proteinases, the cysteine cathepsins, in these processes have been confirmed by numerous clinical reports and evidence accumulated from experimental cancer models. [1] [2] [3] [4] Cathepsins belong to the family of papain-like proteases (clan CA, family C1) and are localized primarily in endosomal and lysosomal compartments. 5, 6 However, under several pathological conditions, these enzymes can escape from endosomal vesicles by being secreted to the extracellular milieu or, alternatively, translocated into the cytosol. 7 Cysteine cathepsins have been shown to have a clear role as tumorpromoting enzymes, [8] [9] [10] suggesting the possibility of anticathepsin therapy in cancer treatment. [11] [12] [13] [14] [15] On the other hand, cysteine cathepsins could participate in induction of tumor cell death through mediation of apoptosis, 16, 17 which, however, requires cytosolic release of these enzymes from lysosomes. 18 An additional level of complexity is introduced by the fact that the proteolytic activity of cysteine cathepsins is regulated by their endogenous inhibitors called cystatins. 19 The endogenous protein inhibitors of cysteine cathepsins, the cystatin superfamily, can be subdivided into three families, stefins (type I), cystatins (type II) and kininogens (type III). 20 In mammals, including human, rat, bovine, mouse and porcine, two members of the type I family, stefin A (cystatin A or a) and stefin B (Stfb; cystatin B or b), have been identified. Both inhibitors are singlechain polypeptides with B100 amino acid residues (molecular mass, B11 kDa) and are localized intracellularly. 21 In contrast to stefin A, which exhibits a restricted expression pattern with especially high levels in skin and some types of blood cells, Stfb is widely distributed in various cell types and tissues. Stfb is considered as a general cytosolic cysteine cathepsin inhibitor in mammalian cells, where it probably serves to protect the cell against inappropriate proteolysis due to cysteine cathepsin leakage from the lysosomes. 22 Moreover, it is one of the cystatins for which genetic evidence points to an important biological function. Loss-of-function alterations in the Stfb gene (either through a multiplied repeat unit in the promoter region or through point mutations in the structural gene) are present in both alleles of the gene in patients with a form of progressive myoclonus epilepsy. 23 Furthermore, because of the important role of cysteine cathepsins in cancer progression, the ratio of cystatins to cysteine cathepsins has been thoroughly investigated. As such, Stfb levels were correlated with diagnosis and prognosis for cancer patients with different malignancies. 24 Strikingly, increased concentrations of Stfb in the body fluids of carcinoma patients have been shown to correlate significantly with shorter survival. 25 Although a higher level of cathepsin inhibitors may counterbalance the upregulation of cysteine cathepsins, their role in cancer still remains poorly defined.
To elucidate the role of Stfb (also known as cystatin B) in cancer progression and metastasis, we have established a Stfb-ablated mouse mammary cancer model by crossing Stfb-deficient mice 26 with a strain of mice susceptible to mammary cancer (polyoma virus middle T oncogene (PyMT) mice), which express the PyMT under control of the mouse mammary tumor virus (MMTV) long-1 terminal repeat promoter. 27 Depletion of Stfb has been shown to result in reduced tumor growth, suggesting a novel function for Stfb in defending tumor cells against oxidative stress.
RESULTS

Progression of PyMT-induced mammary carcinomas
To examine the role of Stfb in the progression of PyMT-induced breast cancer, Stfb-deficient mice (Stfb À / À ) were backcrossed to the FVB/N genetic background for 10 generations. These mice did not show an abnormal behavioral or neurological phenotype at 14 weeks of age, similarly to original Stfb À / À inbred C57BL/6 strain. 26 These mice were further crossed with PyMT transgenic mice, 27 resulting in two groups of female mice, hemizygous for the PyMT transgene: PyMT;Stfb
and PyMT;Stfb À / À . Western blot analyses of Stfb revealed overexpression of this inhibitor in mammary tumors of PyMT transgenic mice, relative to the nontransformed mammary glands (Figure 1a) . Furthermore, immunohistochemical staining of primary PyMT tumors revealed that Stfb was predominantly localized in the tumor cells of PyMT;Stfb þ / þ tumors and not in the cells of tumor stroma (Figure 1b) . To investigate the effect of Stfb deficiency in the context of breast cancer, we have compared PyMT;Stfb þ / þ and PyMT;Stfb À / À transgenic mice for tumor development, progression, proliferation and cell death. To assess the development of mammary tumors in both groups of mice, all 10 mammary glands of each mouse were palpated three times a week, starting on day 30 after birth in a genotype-blind fashion. To evaluate the genotype-dependent differences in the occurrence of the first palpable tumors, we determined the time point at which cancer-prone mice developed the first two tumors. In the PyMT;Stfb À / À group, the first two palpable mammary tumors were detected in all mice at the age of 59 days, which is 6 and 3 days later than in the control PyMT;Stfb þ / þ mice (Figure 1c ). Despite the apparent shift of Kaplan-Meier plots for tumor-free mice between the two Stfb genotypes, no significant difference between these groups was detected. This data excludes major effects of Stfb in initiation of tumor in PyMT mammary cancer model induced by expression of the PyMT transgene. To analyze the effect of Stfb on the progression of established tumors, their diameter was measured 30 days after detection. Tumors were grouped by size into the Figure S1) , corroborating the data on Ki67 immunohistochemistry analysis of the tumor tissue. Interestingly, no difference in cell death ratio was detected by measuring the viability of the tumor cells obtained from tumor cells of the two Stfb genotypes. However, given the predominant localization of Stfb in cytosolic cell compartment, where the lysosomal protease pathway of induction of apoptosis takes place, 28 we decided to investigate the role of Stfb in sensitivity of tumor cells to apoptosis induction. Initially, we have measured expression and activity of cysteine cathepsins in tumor lysates of PyMT;Stfb þ / þ and PyMT;Stfb À / À mice. Notably, although no difference in expression of cysteine cathepsins was determined by quantitative real-time PCR (Figure 3a) , almost a two-fold increase in cathepsin activity was detected in PyMT;Stfb À / À tumors (Figure 3b ), indicating an important role of this inhibitor in regulation of cathepsins activity. To induce the lysosomal pathway of apoptosis, destabilization of lysosomal membranes in tumor cells of both Stfb genotypes was stimulated by the lysosomotropic detergent Leu-Leu-OMe. Treatment of cells with Leu-Leu-OMe is known to induce cysteine cathepsin leakage into the cytosol, where they degrade the antiapoptotic Bcl-2 family members Bcl-2, Bcl-xL and Mcl-1, and process another Bcl-2 family member Bid into its pro-apoptotic form tBid, 16, 17 leading to activation of the intrinsic apoptosis pathway and activation of caspases 3 and 7. Stfb-ablated primary tumor cells were significantly more sensitive to this apoptotic stimulus, resulting in an up to 85% increase in cell death in PyMT;Stfb À / À cells, as compared with the 30% of apoptotic cells in PyMT;Stfb þ / þ tumor cells at 1 mM Leu-Leu-OMe concentration (Figure 3c ). This sensitivity of Stfb-depleted tumor cells to a cell death stimulus suggests a possible role of this inhibitor as a 'cell guard' against apoptosis induced by cathepsins. This hypothesis was confirmed by the use of the synthetic cysteine cathepsin inhibitor E64d, which almost completely protected tumor cells from apoptosis (Figure 3c ), resulting in an almost fourfold reduction of the number of apoptotic cells. We next measured DEVDase activity of tumor cells after treatment with Leu-Leu-OMe, and found it to be threefold higher in Stfb-depleted tumor cells (Figure 3d ), supporting the above idea. However, upon induction of apoptosis with an anti-CD95 (Fas/APO-1) monoclonal antibody, no significant difference was detected between PyMT;Stfb þ / þ and PyMT;Stfb À / À tumor cells as reflected by the number of annexin V-positive cells (Figure 3e ). This supports the previous findings that cathepsin release from lysosomes is not a major event in Fasinduced apoptosis, 29 thereby providing evidence that the increased level of cell death in Stfb-deficient tumors could not be induced by the Fas/CD95 signaling pathway.
Oxidative stress was recently identified as one of the pivotal factors provoking cell death in Stfb-ablated neurons, which leads to progressive myoclonus epilepsy disorder. 30 Because malignant cells in general are under intrinsic oxidative stress, and are thus more vulnerable to damage by reactive oxygen species (ROS)-generating agents, 31 we have investigated the effect of Stfb deficiency on the sensitivity of tumor cells to induced oxidative stress. Primary tumor cells of both Stfb genotypes, PyMT;Stfb þ / þ and PyMT;Stfb À / À , were exposed to hydrogen peroxide (H 2 O 2 ), a representative ROS, and tumor cell death was assessed by annexin V staining (Figure 4a ). Notably, a significant increase in the percentage of annexin V-positive cells was detected in PyMT;Stfb À / À primary tumor cells, as compared with wild-type PyMT;Stfb þ / þ cells (Figure 4b ). Moreover, a fivefold increase of DEVDase activity was determined in PyMT;Stfb À / À primary tumor cells upon exposure to 1 mM H 2 O 2 , whereas no difference in caspase activity was detected in wild-type PyMT;Stfb þ / þ cells (Figure 4c ). This data indicates an increased sensitivity of Stfbdepleted cells to oxidative stress, through induction of apoptotic cell death.
The lack of blood supply in the fast-growing tumors leads to deprivation of nutrients and growth factors that causes increased levels of intracellular ROS. 32 Thereby, we have cultured PyMT;Stfb þ / þ and PyMT;Stfb À / À cells in serum-free medium (also known as serum starvation) to mimic tumor cell oxidative stress in cell culture. Notably, an increase in tumor cell death was detected in PyMT;Stfb example, E-cadherin. Second, they participate in the apoptotic pathways. Although these two activities have apparently opposing functions, there is a clear physical separation of the processes in different cell compartments, allowing for the possibility of their selective targeting. 7 Although the proteolysis required for tumor invasion occurs mostly in the extracellular space, 1,2 the apoptotic pathway is clearly intracellular and dependent on translocation of cathepsins from the endosomal/lysosomal compartment into the cytosol. 5, 18 In the present study, we have investigated the role of Stefin B promotes tumor cell resistance to oxidative stress M Butinar et al the intracellular inhibitor of cysteine cathepsins, Stfb, which is localized predominantly in the cytosol, 22 where it serves to protect the cell against leakage of lysosomal enzymes. Consistent with that, depletion of Stfb had no effect on tumor invasion and metastasis-related processes (data not shown) that require translocation of cysteine cathepsins to the extracellular milieu. In contrast, significant reduction of tumor size and weight was observed in the PyMT;Stfb À / À group of mice, which correlated with the increased level of tumor cell death in tumors depleted of Stfb (Figure 2c-f) . Surprisingly, given the well-substantiated role of cysteine cathepsins in various cell death pathways, no difference in spontaneous levels of apoptosis was detected between PyMT;Stfb þ / þ and PyMT;Stfb À / À primary tumor cells. However, according to current knowledge, cysteine cathepsins must be released into the cytosol in order to be involved in propagation of apoptosis. 33 To enable this, lysosomal membrane destabilization is required, which could be triggered by different lysosomotropic compounds, such as detergents, including the amino acid methyl ester Leu-Leu-OMe, 16, 17, 34, 35 which are able to induce lysosomal membrane permeabilization. In agreement with that, a significant increase in apoptosis was observed in Stfbdepleted primary PyMT tumor cells as compared with the wild-type tumor cells (Figure 3c and d) . Moreover, this result is consistent with the previous report on depletion of cysteine cathepsin B in the same tumor model, where primary tumor cells were significantly less sensitive to apoptosis induced by Leu-Leu-OMe. 36 Furthermore, lysosomal membranes can be destabilized by low concentrations of H 2 O 2 , [37] [38] [39] [40] which is a physiological mediator of cell death. Growing evidence suggests that cancer cells produce high levels of ROS and are constantly under oxidative stress. 31, [41] [42] [43] Moreover, it is generally accepted that oxidative stress has an important role in apoptosis in carcinomas. H 2 O 2 is a ubiquitous ROS that is generated from nearly all sources of oxidative stress and can freely cross cell membranes. It has been widely used to model ROS-induced apoptosis in experimental situations. [44] [45] [46] Recently, H 2 O 2 -dependent lysosomal destabilization has been described in human prostate cancer PC-3 cells 47 and in human leukemia HL-60 cells. 38 Moreover, an involvement of lysosomal cysteine proteinases has been confirmed in the latter study by the use of E64d inhibitor. These data propose that in the absence of Stfb the protection of cells against ROS-induced apoptosis could be reduced. This hypothesis is supported by the results of Lehtinen et al., 30 who have shown that knocking out Stfb or reducing its levels sensitizes cerebellar granule neurons to oxidative stress-induced cell death, resulting in neuronal death and degeneration. 30 This explains why the absence of this inhibitor triggers progressive degeneration of cerebellar granule neurons, leading to progressive myoclonus epilepsy (EPM1). 23 In our study, we have clearly demonstrated an increased sensitivity of breast tumor cells lacking Stfb to H 2 O 2 and serum starvationinduced apoptosis compared with the wild-type tumor cells (Figure 4 and Supplementary Figure S2) . This not only is in agreement with previous findings on cerebellar granule neurons but also suggests a novel function for Stfb in defending tumor cells from oxidative stress. Moreover, the recent findings on sensitization of thymocytes to staurosporin-induced apoptosis 48 and melanoma cells to tumor necrosis factor-related apoptosisinducing ligand-induced apoptosis, 49 upon gene knockout or short hairpin RNA knockdown of Stfb, respectively, support the protective function of Stfb against apoptosis. Interestingly, a role of Stfb in stabilization of the FADD like IL beta converting enzyme (FLICE)-like inhibitory protein, which can interrupt apoptotic signaling at the death-inducing signaling complex (DISC) level by competing with caspase-8 for binding to Fas Associated protein with death domain (FADD), was recently discovered on melanoma cell lines, 49 thus proposing a cathepsin activityindependent function for Stfb. Furthermore, the results on the tumor-protective role of Stfb may explain the clinical data showing that higher levels of Stfb in tumor tissues and body fluids are associated with poor prognosis for patients with different types of cancer. These reports are also supported by the recent data on a proteome analysis of differentially expressed proteins by mass spectrometry, where Stfb was identified as a tissue and urinary biomarker of bladder cancer recurrence and progression. 50 Moreover, elevated Stfb level was also determined as the most significant variable predicting disease recurrence and grade/stage progression of transitional cell carcinoma. 50 Interestingly, depletion of extracellular cysteine cathepsin inhibitor, cystatin C, results in a reduction of epithelial cell apoptosis and increase of proliferation and angiogenesis in a mouse model of multistage epithelial carcinogenesis. 51 Thus, collectively, the results of Yu et al. 51 and our data provide additional evidence for the importance of the subcellular localization of the disrupted protease-protease inhibitor counterbalance for the impact on tumor progression: extracellular for cystatin C and cytosolic for Stfb. Moreover, the data for another intracellular inhibitor of cysteine cathepsins, stefin A, corroborate this hypothesis revealing the association of stefin A expression with poor histological differentiation, high proliferative activity and increased risk of death in tumors of breast cancer patients. 52 Furthermore, similarly to our Stfb model, tumors positive for stefin A were larger than stefin A-negative tumors. 52 Carcinoma cells synthesize ROS at a high rate, and many tumors thus appear to be under persistent oxidative stress. 41 However, many cancer cells become well adapted to such stress and develop resistance to oxidative stress and ROS-mediated apoptosis. Our results suggest an important role of Stfb for building up such resistance by protecting cells against apoptosis, thereby promoting tumor cell survival and cancer progression. This underlines the need for further research of the molecular signaling pathways regulated by the protease inhibitors 53 and the development of new strategies for cancer therapy to enhance therapeutic activity and selectivity. 
MATERIALS AND METHODS Animals
Mice were used in accordance with protocols approved by the Veterinary Administration of the Republic of Slovenia and the government Ethical Committee. Procedures for animal care and use were in accordance with the 'PHS Policy on Human Care and Use of Laboratory Animals' and the 'Guide for the Care and Use of Laboratory Animals'. The Stfb-deficient mouse strain was kindly provided by Dr Richard M. Myers. 26 Stfb À / À mice were backcrossed for eight generations to the transgenic mouse strain expressing PyMT under the control of MMTV long-terminal repeat promoter (FVB/N-TgN (MMTVPyVT)634-Mul). 27 After the intercross, wildtype and Stfb-deficient tumor bearing mice were named PyMT;Stfb þ / þ and PyMT;Stfb À / À , respectively. Animals were bred and maintained in accordance with the Slovenian law for animal protection.
Tumor progression study
Beginning at age 30 days, female mice were examined three times a week for the development of mammary tumors by finger palpation in a genotype-blinded fashion. Their diameters were measured 30 days after being first detected. At the age of 14 weeks, mice were killed and all 10 mammary tumors were excised and weighted.
Histomorphometry
For volumetric measurement of total lung metastasis or disseminated tumor colonies in lungs, the paraffin-embedded lungs were cut into 5-mm thick slices from at least three different planes. Each section was stained with hematoxylin and eosin. The average metastasis size was determined by computer-assisted measurement using Cellquest software (Olympus, Tokyo, Japan).
Immunohistochemistry and immunofluorescence
Histological measurement of proliferation by Ki67 staining, cell death and tumor vascularization rate by CD31 staining were done as described. 9, 36 Right (thoracic) mammary glands were sectioned, and tissue sections for each tumor were taken from PyMT;Stfb þ / þ and PyMT;Stfb À / À mice. Rabbit anti-active caspase-3 antibody (Abcam ab2302, Cambridge, UK; 1:40 dilution) was used to detect apoptotic epithelial and cancer cells. Rabbit anti-mouse Stfb antibodies (Abcam, Cambridge, UK, ab53725; 1:1000 dilution) were used for immunohistochemical detection of Stfb. Detection of primary antibodies was done by Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA) in accordance to the manufacturer's instructions, followed by incubation with 3,3-DAB (Sigma-Aldrich, Steinheim, Germany) and nuclear staining with hematoxylin. For Ki67 data assessment, 20 fields per tumor were selected at random, using a Â 40 objective, and quantified using TissueQuest software (TissueGnostics, Vienna, Austria). Areas of dead cells in tumor sections were determined using the ApoptTag Peroxidase In Situ apoptosis detection Kit (Millipore, Billerica, MA, USA) and an Olympus microscope (Olympus IX 81) with Imaging Software for Life Science Microscopy Cell. For vascularization, samples were co-stained and mounted in SlowFade Gold antifade reagent with DAPI (Invitrogen) and examined with an Olympus fluorescence microscope (Olympus IX 81) with Imaging Software for Life Science Microscopy Cell.
Isolation of primary tumor cells from PyMT-induced mammary carcinomas
Primary MMTV-PyMT cells were isolated and cultured as described. 10 Only low-passage number cells (o4 passages total) were used for experiments. All primary cells were maintained in DMEM (Gibco, (Invitrogen), Paisley, Scotland, UK) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St Louis, MO, USA), 2 mM L-glutamine (Invitrogen), 100 U of penicillin and 100 mg/ml streptomycin (Invitrogen). Cultured cells were maintained at 37 1C in a humidified 5% CO 2 atmosphere.
Quantitative real-time PCR Total RNA was isolated from flash-frozen PyMT mammary tumors with an Allprep DNA/RNA/Protein Mini kit (Qiagen, Valencia, CA, USA) and treated with TURBO DNA-free kit (Ambion, Life Technologies, Foster City, CA, USA) for genomic DNA elimination. RNA quality (A260/230 and A260/280 ratios) was assessed spectrophometrically, whereas RNA integrity was confirmed by 1.2% gel electrophoresis. RNA was further reverse transcribed into cDNA with a random nanomer primers using Precision nanoScript Reverse Transcription kit (Primerdesign Ltd, Southampton, UK). mRNA expression levels of cathepsin B, cathepsin S, cathepsin X and cathepsin H were detected by SYBR green detection chemistry using 2 Â Precision MasterMix (Primerdesign Ltd). Eukaryotic translation initiation factor 4A2 was selected as the most stable expressed reference gene by GeNorm reference gene selection kit (Primerdesign Ltd), and normalized values were used to calculate the relative mRNA expression of individual genes. Quantitative real-time PCR reaction was run on Mx3005P Real-time PCR system (Agilent, Stratagene products, Waldbronn, Germany) using the following conditions: 95 1C for 10 min (an initial denaturation step) followed by 40 
Induction of apoptosis
Apoptosis was induced with anti-CD95 monoclonal antibody Jo-2 (BD Pharmingen, San Diego, CA, USA) at a final concentration of 0.2 mg/ml in the presence of cyclohexamide (CHX) for 18 h. The mediator of oxidative stress, H 2 O 2 , was applied at a final concentration of 1 mM for 18 h. The lysosomotropic agent Leu-Leu-OMe was applied at final concentration of 1 mM with or without 20 mM E64d for 18 h. 16 At indicated time points, cells were harvested and lysed (50 mM HEPES, 200 mM NaCl, 0.1% (w/v) CHAPS, 10% (w/v) sucrose, 5 mM MgCl 2 , 0.02 (w/v) BSA, 1% (w/v) NP-40 and 0.5% (w/v) Triton X-100) on ice then centrifuged at 10000 g (10 min), and supernatants were separated. Total protein concentration was determined using the Bradford assay (Bio-Rad, Mü nchen, Germany). Cells, untreated and treated with anti-CD95 monoclonal antibody, 1 mM H 2 O 2 or 1 mM LeuLeu-OMe, were labeled with annexin V-phycoerythrin/7AAD (BD Pharmingen). Exposure to phosphatidylserine and DNA fragmentation were measured by labeling cells with annexin V-phycoerythrin in the presence of propidium iodide according to the manufacturer's instructions. Cells were then subjected to flow cytometry (fluorescence-activated cell sorting) analysis using FACScalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).
Cathepsin activity in mammary tumor lysates
Frozen tissues of primary tumors were disrupted in 200 ml of 0.1 M TRIS buffer pH 8.5, 5 mM EDTA, 200 mM sodium chloride and 0.2% SDS, using an Ultrathurrax (IKA, Staufen, Germany), and centrifuged at 1000 g for 10 min. Cysteine cathepsin activity was determined by hydrolysis of the general cathepsin substrate Z-Phe-Arg-4-methyl-coumarin-7-amide (Z-Phe-Arg-AMC, 10 mM; Bachem, Bubendorf, Switzerland) in 0.1 M phosphate buffer, pH 6.0, containing 1 mM EDTA, 0.1% (v/v) polyethylene glycol and 1 mM dithiothreitol, in the presence or absence of E64 cysteine cathepsin inhibitor at a final concentration of 10 mM. Kinetics of substrate hydrolysis were monitored continuously during 10 min by Tecan Infinite M1000 PRO (Tecan, Grö ding, Austria) plate reader at excitation and emission wavelengths of 370 and 460 nm, respectively.
DEVDase activity
Cell lysates (75 mg of protein) were transferred into a black 96-well plate. Caspase buffer (50 mM HEPES, 200 mM NaCl, 0.1% (w/v) CHAPS, 10% (w/v) sucrose, 5 mM MgCl2 and 0.02 (w/v) BSA) was added to a final volume of 90 ml and incubated for 15 min at 37 1C. A volume of 10 ml acetyl-DEVD-7-amino-4-trifluoromethylcoumarin (Bachem) was added to a final concentration of 100 mM, and DEVDase activity was measured by Tecan Infinite M1000 PRO (Tecan) plate reader at excitation and emission wavelengths of 400 and 505 nm, respectively.
Immunoblotting
Equal amounts (100 mg) of protein were resolved on 12.5% SDS polyacrylamide gel electrophoresis gels and electrotransferred to polyvinylidene difluoride membranes. Blots were probed with rabbit anti-Stfb Stefin B promotes tumor cell resistance to oxidative stress M Butinar et al antibodies (Abcam; ab53725, 1:1000 dilution) and rabbit anti-actin antibodies (Sigma-Aldrich) at 1:800 and 1:2000 dilutions, respectively. Secondary conjugated goat anti-rabbit antibodies were used at 1:5000 dilutions.
Statistical analysis
Quantitative data are presented as means±s.e. The differences were compared using Student's t-test. Proportions were compared using the w 2 -test, and statistical analysis of Kaplan-Meier plots was done by log-rank test. When P-values were p0.05, differences were considered statistically significant.
